Selective PolI inhibitors block rDNA transcription, disrupt nucleolar function, and were shown to selectively kill tumor cells in vivo while sparing normal cells, presumably as a result of impaired ribosome biogenesis (Hannan et al. 2013a, b; Hein et al. 2013). The gene discussed is POLI; the disease is neoplasm.